biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > The greatest investment advice E given by our Forum Buffoon

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Jan 02, 2024 11:35am

149 Views

Post# 35807117

RE:RE:The greatest investment advice E given by our Forum Buffoon

beenthere wrote: " Hopefully the Bioasis chapter finally ends this year,

and it ends well for those still holding"

??? wtf ???

Confusing for you beenthere?

Yes, for those people here still holding Bioasis shares, I "hope it ends well" for them, and they make money or atleast break even.

Not sure what is so hard for you to understand??

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market